Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delgocitinib plus topical corticosteroid multilayer therapy in pediatric atopic dermatitis
jRCTs031240119Completed
- Sponsor
- Torii Pharmaceutical
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of delgocitinib in atopic dermatitis (AD) (2 arms), sponsored by Torii Pharmaceutical. Started Jun 2024; status: completed.
02
Drugs
delgocitinib
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCTs031240119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240119.